10
LEARNING MODULE TITLE SUBTITLE

LEARNING MODULE TITLE

  • Upload
    tamah

  • View
    29

  • Download
    0

Embed Size (px)

DESCRIPTION

LEARNING MODULE TITLE. SUBTITLE. HISTORY OF PRESENT ILLNESS. An 18 year-old woman with no past medical history and no known risks for TB presents with several months of cough, weight loss, and fatigue. She had no underlying medical problems No known contacts with MDR-TB patients. INITIAL CXR. - PowerPoint PPT Presentation

Citation preview

Page 1: LEARNING MODULE TITLE

LEARNING MODULE TITLESUBTITLE

Page 2: LEARNING MODULE TITLE

HISTORY OF PRESENT ILLNESS

An 18 year-old woman with no past medical history and no known risks for TB presents with several months of cough, weight loss, and fatigue.

• She had no underlying medical problems• No known contacts with MDR-TB patients.

Page 3: LEARNING MODULE TITLE

INITIAL CXR

Page 4: LEARNING MODULE TITLE

DIAGNOSIS

• She was determined to be at risk for TB based on her symptoms and underwent testing.

• Her sputum was found to be smear positive with 3+ AFB.

Page 5: LEARNING MODULE TITLE

CLINICAL COURSE

• Two months after starting therapy, the patient had worsening shortness of breath and cough. – She was compliant with her TB treatment.

• She came to the hospital and had sputum that was smear + and an CXR that showed the following findings.

Page 6: LEARNING MODULE TITLE

The CXR showed a collapsed left lung. The patient underwent a bronchoscopy to visualize the airway to determine the problem in the left lung.

FOLLOW-UP CXR

Page 7: LEARNING MODULE TITLE

Bronchoscopy showed tuberculosis at the end of the airway (endobronchial TB) in the left airway. The patient underwent dilation of the airway and was continued on first-line drugs.

BRONCHOSCOPY

Page 8: LEARNING MODULE TITLE

CLINICAL COURSE

• The patient continued her first line drug regimen with good adherence and compliance

• After 5 months on therapy, her sputum smear remained positive (1+/2+).

• Sputum culture and drug susceptibility testing showed resistance to INH and Rifampicin, meeting the diagnosis for MDR-TB.

Page 9: LEARNING MODULE TITLE

MDR-TB DIAGNOSIS

• The patient was switched to second-line drugs for MDR regimen, and she has steadily improved while on treatment.

• Her last CXR was ***• Her last sputum smear/culture was ***• She has *** months left on treatment

Page 10: LEARNING MODULE TITLE

TEACHING POINTS

• What are the classic risk factors for MDR-TB?• In patients without these classic risk factors,

when would you think of testing for MDR-TB?• What are the symptoms and signs of collapsed

lobes of the lung?• What is the treatment and follow-up for

endobronchial TB?